Featured publications

  • Understanding the microenvironment contribution to ductal carcinoma in situ transition to invasiveness in breast cancer

    Authors:
    Moragas, Nuria; Recalde-Percaz, Leire; Noguera-Castells, Aleix; Fernandez-Nogueira, Patricia; Mancino, Mario;
    Gascon, Pedro; Fuster, Gemma.
    Reference: CANCER RESEARCH.
  • Glucocorticoids mediate DCIS transition to IDC through myoepithelial cell apoptosis

    Authors:
    Zubeldia-Plazaola, Arantzazu; Recalde-Percaz, Leire; Moragas, Nuria; Mancino, Mario; Noguera, Aleix;
    Prats de Puig, Miquel; Guzman, Flavia; Gascon, Pedro; Bragado, Paloma; Fuster, Gemma.
    Reference: CANCER RESEARCH.
  • HRH1 inhibition enhances antitumor therapeutic responses through ERK activation in breast cancer

    Authors:
    Fernandez-Nogueira, Patricia; Noguera-Castells, Aleix; Fuster, Gemma; Recalde, Leire; Moragas, Nuria;
    (...)
    Jauregui, Patricia; Gascon, Pere; Carbo, Neus; Bragado, Paloma; Mancino, Mario;.
    Reference: CLINICAL AND EXPERIMENTAL METASTASIS.
  • STX1A signaling pathway characterization in different breast cancer subtypes

    Authors:
    Noguera-Castells, Aleix; Recalde-Percaz, Leire; Moragas, Nuria; Fernandez-Nogueira, Patricia; Fuster, Gemma;
    Bragado, Paloma; Gascon, Pere; Mancino, Mario;.
    Reference: CLINICAL AND EXPERIMENTAL METASTASIS.
  • NRP2-SEMA3s-PLXNs axis regulates the dormancy state of disseminated tumour cells and metastasis progression

    Authors:
    Recalde-Percaz, Leire; Noguera-Castells, Aleix; Moragas, Nuria; Mancino, Mario; Fernandez-Nogueira, Patricia;
    Fuster, Gemma; Gascon, Pere; Bragado, Paloma;.
    Reference: CLINICAL AND EXPERIMENTAL METASTASIS.
  • Substance P and its receptor NK1 regulates disseminated tumour cells biology and dormancy

    Authors:
    Recalde-Percaz, Leire; Jauregui, Patricia; Fernandez-Nogueira, Patricia; Alonso, Raul; Fuster, Gemma;
    Noguera-Castells, Aleix; Moragas, Nuria; Mancino, Mario; Gascon, Pere; Bragado, Paloma;.
    Reference: CLINICAL AND EXPERIMENTAL METASTASIS.
  • The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase

    Authors:
    Erazo, Tatiana; Lorente, Mar; Lopez-Plana, Anna; Munoz-Guardiola, Pau; Fernandez-Nogueira, Patricia;
    (...)
    Gomez-Ferreria, Mariana; Alfon, Jose; Velasco, Guillermo; Domenech, Carles; Lizcano, Jose M.;.
    Reference: CLINICAL CANCER RESEARCH.
  • Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancer

    Authors:
    Fernández-Nogueira P.; Noguera-Castells A.; Fuster G.; Recalde-Percaz L.; Moragas N.;
    (...)
    Carbó N.; Almendro V.; Gascón P.; Bragado P.; Mancino M..
    Reference: CANCER LETTERS.
  • Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.

    Authors:
    Lugo R; Gabasa M; Andriani F; Puig M; Facchinetti F;
    (...)
    Gascón P; Davalos A; Reguart N; Roz L; Alcaraz J .
    Reference: ONCOTARGET 2016.

Featured Projects

  • Red temática de Investigaciones cooperativa del cáncer

    Principal investigator: Pere Gascón Vilaplana
    Funder: INSTITUTO DE SALUD CARLOS III
    Duration: 01/01/2013
  • Plasticidad epigenética durante la adquisición de quimioresistencia en cáncer de colon

    Principal investigator: Cristina Nadal
    Funder: INSTITUTO DE SALUD CARLOS III
    Duration: 01/01/2012